Antiplatelet Agents for Patients Undergoing PCI: Options and Pharmacologic Considerations
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Boston Scientific Corporation; Medtronic
- Grant Support/Research Contract - Boston Scientific Corporation; Medtronic